Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pressure Biosciences
(OP:
PBIO
)
0.1800
-0.0389 (-17.77%)
Streaming Delayed Price
Updated: 3:48 PM EDT, Jun 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Pressure Biosciences
< Previous
1
2
3
4
5
6
7
8
Next >
Pressure BioSciences Invites Stakeholders, Fund Managers, and Investors to Attend a Webinar on PBIO's Revolutionary UltraShear Technology Platform
June 26, 2023
Via
ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Inks Agreement to Provide VST Members with UltraShear Nano-CBD, Other Products
June 13, 2023
Via
Investor Brand Network
Pressure BioSciences Partners with Veterans Service Team to Offer Exclusive Access for VST Members to a Unique, Custom-Made, UltraShear Nano-CBD & Other Products
June 13, 2023
Via
ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to be Featured on New to The Street Series
June 01, 2023
Via
Investor Brand Network
Pressure BioSciences, Inc. Q1 2023 Financial Results Achieve All-Time Quarterly Record
May 16, 2023
Via
ACCESSWIRE
Pressure BioSciences Announces Expansion into Strategic Manufacturing Facilities with Premier Process Technologies Company, Artisan Industries
April 18, 2023
Via
ACCESSWIRE
Pressure BioSciences Updates Forecast with Six Key Goals for June 2023 with Expected Multi-Million Dollar Growth Increments in FY 2023 and Beyond
June 01, 2023
Via
ACCESSWIRE
Pressure BioSciences Announces Commercial Availability of Best-in-Class Nano-CBD Topical Spray, Featuring Lightning-Fast Action from PBI's UltraShear Processing
May 22, 2023
Via
ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Achieves Record Financial Results in Q1 2023
May 16, 2023
Via
Investor Brand Network
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Eyes New Opportunities, Looks to ‘Watershed’ Year as Focus Groups Report Impressive Results
May 10, 2023
Via
Investor Brand Network
Topics
Cannabis
Exposures
Cannabis
Pressure BioSciences, Inc. to Discuss Fiscal Year 2022 Financial Results and Provide 2023 Business Update and Guidance
April 13, 2023
Via
ACCESSWIRE
Pressure BioSciences and NutraLife Biosciences Renew Partnership for Development and Distribution of Next Generation Nutraceuticals
April 06, 2023
Via
ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Looks to ‘Watershed’ Year as Focus Groups Report Impressive Results, Benefits
May 10, 2023
Via
Investor Brand Network
Topics
Cannabis
Exposures
Cannabis
Pressure BioScience’s Pressure-Based Tech Is Ready To Spur Innovation And Growth In A Life Sciences Sector In Flux
May 10, 2023
Via
ACCESSWIRE
Extended Consumer Testing Strongly Validates Market Transforming Speed and Dosing Efficiency of Pressure BioSciences UltraShear Processed Nano-THC Oral Spray
May 09, 2023
Via
ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Rapid Progress on Limited Offering of Exclusive THC Licenses for UST(TM) Platform
April 26, 2023
Via
Investor Brand Network
Pressure BioSciences Reports Fresh Sales Momentum for PBI Agrochem
March 28, 2023
Via
ACCESSWIRE
Pressure BioSciences Updates Rapid Progress on Limited Offering of Exclusive THC Licenses for Revolutionary UltraShear Nanoemulsion Processing Platform
April 26, 2023
Via
ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Changes to Exclusive UltraShear Nanoemulsion Processing Platform Licenses
April 21, 2023
Via
Investor Brand Network
Topics
Cannabis
Exposures
Cannabis
Pressure BioSciences Unveils Powerful THC Market Leapfrog Opportunity with Exclusive Licensing of Their Revolutionary UltraShear Nanoemulsion Processing Platform
April 21, 2023
Via
ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO), Artisan Industries Inc. Enter Strategic Agreement
April 19, 2023
Via
Investor Brand Network
Pressure BioSciences Receives $1.5M Contract for UltraShear Nanoemulsified CBD
March 22, 2023
Via
ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Schedules Conference Call, Announces Q4 and FY 2022 Financial Results, 2023 Guidance
April 14, 2023
Via
Investor Brand Network
Pressure BioSciences, Inc. Reports Q4 and FY 2022 Financial Results, Provides Business Update, and Offers Guidance for a Strong 2023
April 14, 2023
Via
ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO), NutraLife Biosciences Partner to Develop, Distribute Next-Generation Nutraceuticals
April 06, 2023
Via
Investor Brand Network
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Eyes Growing Demand for Eco-Friendly Agrochem Products
March 28, 2023
Via
Investor Brand Network
Pressure BioSciences Announces the Exchange of Over $10 Million of Debt into Equity
March 01, 2023
Via
ACCESSWIRE
$1.5 Million Marketing Contract for Best-in-Class UltraShear Nanoemulsified Skin Care Products: Pressure BioSciences, Inc. (Stock Symbol: PBIO)
March 22, 2023
Via
Get News
Topics
Cannabis
Supply Chain
Exposures
Cannabis
Supply Chain
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces $1.5M Order for Proprietary UltraShear Nanoemulsified CBD
March 22, 2023
Via
Investor Brand Network
Topics
Cannabis
Supply Chain
Exposures
Cannabis
Supply Chain
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Largest Investor Exchanges $10M-Plus Debt into Non-Secured Equity
March 01, 2023
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.